📊 ALGN Key Takeaways
Is Align Technology Inc. (ALGN) a Good Investment?
Align Technology demonstrates financial stability with a fortress balance sheet, zero debt, and consistent free cash flow generation, but faces fundamental growth challenges with revenue growth of just 0.9% YoY and concerning low returns on capital (ROE 2.7%, ROA 1.8%), suggesting potential market saturation in its core orthodontic business.
Align Technology shows solid underlying fundamentals with high gross margins, positive free cash flow generation, and a debt-free balance sheet supported by over $1 billion in cash. Profitability remains healthy, but the latest period shows only modest revenue growth and slightly lower net income, which suggests the business is financially strong but not currently in a high-growth phase. Overall, the company appears fundamentally resilient with good earnings quality, though future upside depends on reaccelerating growth while preserving margins.
Why Buy Align Technology Inc. Stock? ALGN Key Strengths
- Exceptional 70.8% gross margins indicating strong pricing power and operational efficiency in orthodontic appliances
- Zero debt with $1.1B cash position and 1.39x current ratio providing financial flexibility and stability
- Consistent free cash flow generation of $120.3M (11.6% FCF margin) enabling self-funding and potential shareholder returns
- High gross margin of 67.2% supports strong unit economics
- Debt-free capital structure and strong liquidity reduce financial risk
- Free cash flow of $490.78M demonstrates solid cash conversion and operating discipline
ALGN Stock Risks: Align Technology Inc. Investment Risks
- Stagnant revenue growth of just 0.9% YoY signals market saturation or competitive pressures in core Invisalign product line
- Severely depressed return metrics (ROE 2.7%, ROA 1.8%) indicate inefficient capital deployment and poor capital allocation decisions
- Operating margin compression (13.6%) relative to gross margin (70.8%) suggests rising SG&A and operating expense burdens
- Revenue growth of only 0.9% suggests limited near-term expansion momentum
- Net income declined 2.6% year over year, indicating some pressure on bottom-line growth
- ROE of 10.1% is respectable but not especially strong for a premium medical technology business
Key Metrics to Watch
- Revenue growth trajectory - need evidence of market expansion or new product adoption beyond core Invisalign
- Return on equity and return on assets - critical to understand if capital deployment improves efficiency
- Free cash flow deployment strategy - capital allocation decisions with dividends, buybacks, M&A, or R&D investments
- Revenue growth and case volume expansion
- Operating margin and free cash flow margin
Align Technology Inc. (ALGN) Financial Metrics & Key Ratios
💡 AI Analyst Insight
Align Technology Inc. presents a mixed fundamental picture. Review the detailed metrics above to form your own investment thesis.
ALGN Profit Margin, ROE & Profitability Analysis
ALGN vs Healthcare Sector: How Align Technology Inc. Compares
How Align Technology Inc. compares to Healthcare sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Align Technology Inc. Stock Overvalued? ALGN Valuation Analysis 2026
Based on fundamental analysis, Align Technology Inc. has mixed fundamental signals relative to the Healthcare sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Align Technology Inc. Balance Sheet: ALGN Debt, Cash & Liquidity
ALGN Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: Align Technology Inc.'s revenue has shown modest growth of 2% over the 5-year period. The most recent EPS of $5.81 reflects profitable operations.
ALGN Revenue Growth, EPS Growth & YoY Performance
ALGN Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $979.3M | $93.2M | $1.27 |
| Q3 2025 | $977.9M | $56.8M | $0.78 |
| Q2 2025 | $1.0B | $96.6M | $1.28 |
| Q1 2025 | $979.3M | $93.2M | $1.27 |
| Q3 2024 | $960.2M | $116.0M | $1.55 |
| Q2 2024 | $1.0B | $96.6M | $1.28 |
| Q1 2024 | $943.1M | $87.8M | $1.14 |
| Q3 2023 | $890.3M | $72.7M | $0.93 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
Align Technology Inc. Dividends, Buybacks & Capital Allocation
ALGN SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Align Technology Inc. (CIK: 0001097149)
📋 Recent SEC Filings
❓ Frequently Asked Questions about ALGN
What is the AI rating for ALGN?
Align Technology Inc. (ALGN) has a Combined AI Rating of BUY from Claude (HOLD) and ChatGPT (BUY) with 73% combined confidence, based on fundamental analysis of SEC EDGAR filings.
What are ALGN's key strengths?
Claude: Exceptional 70.8% gross margins indicating strong pricing power and operational efficiency in orthodontic appliances. Zero debt with $1.1B cash position and 1.39x current ratio providing financial flexibility and stability. ChatGPT: High gross margin of 67.2% supports strong unit economics. Debt-free capital structure and strong liquidity reduce financial risk.
What are the risks of investing in ALGN?
Claude: Stagnant revenue growth of just 0.9% YoY signals market saturation or competitive pressures in core Invisalign product line. Severely depressed return metrics (ROE 2.7%, ROA 1.8%) indicate inefficient capital deployment and poor capital allocation decisions. ChatGPT: Revenue growth of only 0.9% suggests limited near-term expansion momentum. Net income declined 2.6% year over year, indicating some pressure on bottom-line growth.
What is ALGN's revenue and growth?
Align Technology Inc. reported revenue of $1.0B.
Does ALGN pay dividends?
Align Technology Inc. does not currently pay dividends.
Where can I find ALGN SEC filings?
Official SEC filings for Align Technology Inc. (CIK: 0001097149) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is ALGN's EPS?
Align Technology Inc. has a diluted EPS of $1.57.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is ALGN a good stock to buy right now?
Based on our AI fundamental analysis in May 2026, Align Technology Inc. has a BUY rating with 73% confidence. The AI analysis suggests favorable fundamentals based on SEC filings. This is not investment advice.
Is ALGN stock overvalued or undervalued?
Valuation metrics for ALGN: ROE of 2.7% (sector avg: 15%), net margin of 10.8% (sector avg: 12%). Compare these metrics with sector averages to assess valuation.
Should I buy ALGN stock in 2026?
Our dual AI analysis gives Align Technology Inc. a combined BUY rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is ALGN's free cash flow?
Align Technology Inc.'s operating cash flow is $151.0M, with capital expenditures of $30.8M. FCF margin is 11.6%.
How does ALGN compare to other Healthcare stocks?
Vs Healthcare sector averages: Net margin 10.8% (avg: 12%), ROE 2.7% (avg: 15%), current ratio 1.39 (avg: 2).